Anavex Life Sciences (AVXL) is a publicly traded Healthcare sector company. As of August 10, 2026, AVXL trades at $3.29 with a market cap of $309.52M and a P/E ratio of -7.17. AVXL moved +0.00% today. Year to date, AVXL is -6.18%; over the trailing twelve months it is -70.22%. Its 52-week range spans $2.26 to $14.44. Rallies surfaces AVXL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Anavex Life Sciences (AVXL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AVXL moved +0.00% today.
| Metric | Value |
|---|---|
| Price | $3.29 |
| Market Cap | $309.52M |
| P/E Ratio | -7.17 |
| EPS | $-0.46 |
| Dividend Yield | 0.00% |
| 52-Week High | $14.44 |
| 52-Week Low | $2.26 |
| Volume | 31.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.36M |
| Net Income | $-39.95M |
| Gross Margin | 0.00% |
AVXL analyst coverage data. Average price target: $0.00.